Sign up to save your podcasts
Or
Share Focus on Cedric Francois, MD, PhD, CEO, Apellis Pharmaceuticals
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Focus on Cedric Francois, MD, PhD, CEO, Apellis Pharmaceuticals
Dr. Francois discusses the epidemiology of geographic atrophy, the pathophysiology of complement inhibition in the treatment of GA, and the latest information on Apellis' Phase 2 and Phase 3 clinical trials.
View all episodes
By Retina Synthesis
4.5
88 ratings
Dr. Francois discusses the epidemiology of geographic atrophy, the pathophysiology of complement inhibition in the treatment of GA, and the latest information on Apellis' Phase 2 and Phase 3 clinical trials.
More shows like Retina Synthesis
View all
Ophthalmology off the Grid by Eyetube
43 Listeners
New Retina Radio by Eyetube
18 Listeners
Straight From The Cutter's Mouth: A Retina Podcast
99 Listeners
The Daily
113,159 Listeners
Up First from NPR
56,945 Listeners
JAMA Ophthalmology Author Interviews
5 Listeners
The Indicator from Planet Money
9,560 Listeners
The Retina Channel Podcast
12 Listeners
Dateline NBC
47,707 Listeners
Experts InSight
51 Listeners
RETINA Journal Podcasts
11 Listeners
Knock Knock, Hi! with the Glaucomfleckens
467 Listeners
Ophthalmology Journal
19 Listeners
ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
0 Listeners